$7.08 Million
The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.-
Total revenue in the last quarter.$-236 Thousand
Net income is all revenues minus all expenses including taxes and interest in the last quarter.$-0.02
Earnings per share is the amount of net income that is attributed to each single share outstanding.$0.12 (75.0%)
Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).-6.64x
The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.$-236 Thousand
Earnings before interest expenses and taxes in the last quarter.-
The number of full time employees.Enzon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.
